These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21241513)

  • 21. The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma.
    Kimpel J; Urbiola C; Koske I; Tober R; Banki Z; Wollmann G; von Laer D
    Viruses; 2018 Mar; 10(3):. PubMed ID: 29498639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Applications of coxsackievirus A21 in oncology.
    Bradley S; Jakes AD; Harrington K; Pandha H; Melcher A; Errington-Mais F
    Oncolytic Virother; 2014; 3():47-55. PubMed ID: 27512662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncolytic activity of a coxsackievirus B3 strain in human endometrial cancer cell lines.
    Lin Y; Wang W; Wan J; Yang Y; Fu W; Pan D; Cai L; Cheng T; Huang X; Wang Y
    Virol J; 2018 Apr; 15(1):65. PubMed ID: 29631630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prior Exposure to Coxsackievirus A21 Does Not Mitigate Oncolytic Therapeutic Efficacy.
    Burnett WJ; Burnett DM; Parkman G; Ramstead A; Contreras N; Gravley W; Holmen SL; Williams MA; VanBrocklin MW
    Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Herpes simplex virus oncolytic vaccine therapy in melanoma.
    Sivendran S; Pan M; Kaufman HL; Saenger Y
    Expert Opin Biol Ther; 2010 Jul; 10(7):1145-53. PubMed ID: 20515292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice.
    Vähä-Koskela MJ; Kallio JP; Jansson LC; Heikkilä JE; Zakhartchenko VA; Kallajoki MA; Kähäri VM; Hinkkanen AE
    Cancer Res; 2006 Jul; 66(14):7185-94. PubMed ID: 16849565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NICE guidance for talimogene laherparepvec for unresectable metastatic melanoma.
    Adam J; Robertson J; Donegan E; Voicechovskaja I
    Lancet Oncol; 2016 Nov; 17(11):1485-1486. PubMed ID: 27692478
    [No Abstract]   [Full Text] [Related]  

  • 28. Enterovirus A71 Oncolysis of Malignant Gliomas.
    Zhang X; Wang H; Sun Y; Qi M; Li W; Zhang Z; Zhang XE; Cui Z
    Mol Ther; 2020 Jun; 28(6):1533-1546. PubMed ID: 32304669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1.
    Moehler M; Sieben M; Roth S; Springsguth F; Leuchs B; Zeidler M; Dinsart C; Rommelaere J; Galle PR
    BMC Cancer; 2011 Oct; 11():464. PubMed ID: 22029859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First Oncolytic Viral Therapy for Melanoma.
    Poh A
    Cancer Discov; 2016 Jan; 6(1):6. PubMed ID: 26552414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple Administration Routes, Including Intramuscular Injection, of Oncolytic Tanapoxvirus Variants Significantly Regress Human Melanoma Xenografts in BALB/c Nude Mice Reconstituted with Splenocytes from Normal BALB/c Donors.
    Monaco ML; Idris OA; Filpi GA; Kohler SL; Haller SD; Burr JE; Eversole R; Essani K
    Genes (Basel); 2023 Jul; 14(8):. PubMed ID: 37628585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncolytic intralesional therapy for metastatic melanoma.
    DePalo DK; Perez MC; Huibers A; Olofsson Bagge R; Zager JS
    Clin Exp Metastasis; 2024 Aug; 41(4):457-460. PubMed ID: 37556092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncolytic Tanapoxvirus Expressing Interleukin-2 is Capable of Inducing the Regression of Human Melanoma Tumors in the Absence of T Cells.
    Zhang T; Kordish DH; Suryawanshi YR; Eversole RR; Kohler S; Mackenzie CD; Essani K
    Curr Cancer Drug Targets; 2018; 18(6):577-591. PubMed ID: 28669340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of ICAM-1 Expression on Bladder Carcinoma Cell Lines and Infectivity and Oncolysis by Coxsackie Virus A21.
    Relph K; Arif M; Pandha H; Annels N; Simpson GR
    Methods Mol Biol; 2023; 2684():319-327. PubMed ID: 37410244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models.
    Geletneky K; Kiprianova I; Ayache A; Koch R; Herrero Y Calle M; Deleu L; Sommer C; Thomas N; Rommelaere J; Schlehofer JR
    Neuro Oncol; 2010 Aug; 12(8):804-14. PubMed ID: 20299703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma.
    Miyamoto S; Inoue H; Nakamura T; Yamada M; Sakamoto C; Urata Y; Okazaki T; Marumoto T; Takahashi A; Takayama K; Nakanishi Y; Shimizu H; Tani K
    Cancer Res; 2012 May; 72(10):2609-21. PubMed ID: 22461509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The chicken chorioallantoic membrane tumor assay as model for qualitative testing of oncolytic adenoviruses.
    Durupt F; Koppers-Lalic D; Balme B; Budel L; Terrier O; Lina B; Thomas L; Hoeben RC; Rosa-Calatrava M
    Cancer Gene Ther; 2012 Jan; 19(1):58-68. PubMed ID: 22015640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncolytic Coxsackievirus A21 as a novel therapy for multiple myeloma.
    Au GG; Lincz LF; Enno A; Shafren DR
    Br J Haematol; 2007 Apr; 137(2):133-41. PubMed ID: 17391493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineering Newcastle Disease Virus as an Oncolytic Vector for Intratumoral Delivery of Immune Checkpoint Inhibitors and Immunocytokines.
    Vijayakumar G; McCroskery S; Palese P
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31694938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining adenoviral oncolysis with temozolomide improves cell killing of melanoma cells.
    Quirin C; Mainka A; Hesse A; Nettelbeck DM
    Int J Cancer; 2007 Dec; 121(12):2801-7. PubMed ID: 17724714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.